These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 25319390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL, Zhang ZJ, Yi ZB, Li JJ.
    Br J Cancer; 2017 Jun 27; 117(1):78-88. PubMed ID: 28571042
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.
    Tan X, Peng J, Fu Y, An S, Rezaei K, Tabbara S, Teal CB, Man YG, Brem RF, Fu SW.
    Breast Cancer Res; 2014 Sep 17; 16(5):435. PubMed ID: 25228385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    He R, Liu P, Xie X, Zhou Y, Liao Q, Xiong W, Li X, Li G, Zeng Z, Tang H.
    J Exp Clin Cancer Res; 2017 Oct 16; 36(1):145. PubMed ID: 29037220
    [Abstract] [Full Text] [Related]

  • 8. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J, Lai Y, Ma J, Liu Y, Bi J, Zhang L, Chen L, Yao C, Lv W, Chang G, Wang S, Ouyang M, Wang W.
    BMC Cancer; 2017 Nov 10; 17(1):745. PubMed ID: 29126392
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer.
    Lv ZD, Xin HN, Yang ZC, Wang WJ, Dong JJ, Jin LY, Li FN.
    J Cell Physiol; 2019 Jul 10; 234(7):10819-10826. PubMed ID: 30624764
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J, Song C, Tang H, Zhang C, Tang J, Li X, Chen B, Xie X.
    Breast Cancer Res; 2017 Jun 19; 19(1):72. PubMed ID: 28629464
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
    Pang Y, Liu J, Li X, Xiao G, Wang H, Yang G, Li Y, Tang SC, Qin S, Du N, Zhang H, Liu D, Sun X, Ren H.
    J Cell Mol Med; 2018 Dec 19; 22(12):6262-6274. PubMed ID: 30324719
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-4458 regulates cell proliferation and apoptosis through targeting SOCS1 in triple-negative breast cancer.
    Liu X, Wang J, Zhang G.
    J Cell Biochem; 2019 Aug 19; 120(8):12943-12948. PubMed ID: 30873664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.